Skip to content

Anorectal Manometry Profile In Functional Constipation Or IBS-C: Insights From Eastern India

Study Of Anorectal Manometry Profile Of Patients With Functional Constipation Or Constipation Predominant Irritable Bowel Syndrome In A Tertiary Care Center Of Eastern India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/079568
Enrollment
100
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Control Intervention1: Anorectal Manometry: we will look for Resting pressure(mmHg) Squeeze pressure (mmHg) Type of Dyssynergic defecation Sensory Testing - 1.First sensation (ml) 2.Desire to defeca

Sponsors

IPGMER and SSKM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either gender and age group above 18 years and less than 65 years, chronic constipation of more than 6-month duration defined according to ROME IV criteria (with Bristol stool form I to III) and fulfilling the ROME IV criteria of Functional constipation or constipation-predominant irritable bowel syndrome. 2.Normal sigmoidoscopy/colonoscopy

Exclusion criteria

Exclusion criteria: Patients having Constipation due to secondary causes like mechanical obstruction and drugs. Patients having diabetes mellitus (HbA1c more than 7.5) Patients having thyroid disease (TSH value more than 7) Patients having decompensate liver disease. Patients having Stage 3 and above Chronic kidney disease Patients having history of abdominal surgery except cholecystectomy and appendectomy Patients having history of Gynecological surgery Patients not giving consent

Design outcomes

Primary

MeasureTime frame
Differences in anorectal manometry parameters between functional constipation and constipation predominant irritable bowel syndrome group. Timepoint: At end of study

Secondary

MeasureTime frame
Proportion of patients with dyssynergia. Timepoint: At end of study

Countries

India

Contacts

Public ContactProbal Saha

IPGMER AND SSKMH

dr.arkobanerjee@gmail.com9433454747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026